TBC1D4 and type 2 diabetes mellitus: Type 2 diabetes was shown to decrease expression of Tbc1d4 in skeletal muscle of streptozocin-treated rats [11] and diabetic Goto-Kakizaki rats (in comparison to control Wistar rats) [13].